OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy
Xiaohan Tong, Chunyan Dong, Shujing Liang
Journal of Cancer (2023) Vol. 15, Iss. 1, pp. 54-67
Open Access | Times Cited: 8
Xiaohan Tong, Chunyan Dong, Shujing Liang
Journal of Cancer (2023) Vol. 15, Iss. 1, pp. 54-67
Open Access | Times Cited: 8
Showing 8 citing articles:
The Role of MUC1 in Renal Cell Carcinoma
Martina Milella, Monica Rutigliano, Francesco Lasorsa, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 315-315
Open Access | Times Cited: 25
Martina Milella, Monica Rutigliano, Francesco Lasorsa, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 315-315
Open Access | Times Cited: 25
Prognostic and clinicopathological significance of mucin family members expression in gastric cancer: a meta-analysis
Shunda Wang, Yongrun Mu, Jianwei Zhang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Shunda Wang, Yongrun Mu, Jianwei Zhang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
A fractional-order model for optimizing combination therapy in heterogeneous lung cancer: integrating immunotherapy and targeted therapy to minimize side effects
David Amilo, Chinedu Izuchukwu, Khadijeh Sadri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
David Amilo, Chinedu Izuchukwu, Khadijeh Sadri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Targeting Interleukin-13 Receptor α2 and EphA2 in Aggressive Breast Cancer Subtypes with Special References to Chimeric Antigen Receptor T-Cell Therapy
Dharambir Kashyap, Huda Salman
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3780-3780
Open Access | Times Cited: 1
Dharambir Kashyap, Huda Salman
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3780-3780
Open Access | Times Cited: 1
Prostate-Specific Membrane Antigen Biology and Pathophysiology in Prostate Carcinoma, an Update: Potential Implications for Targeted Imaging and Therapy
Justine Maes, Simon Gesquière, Anton De Spiegeleer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9755-9755
Open Access | Times Cited: 1
Justine Maes, Simon Gesquière, Anton De Spiegeleer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9755-9755
Open Access | Times Cited: 1
Targeting the MUC1 tumor marker with an antibody improves the therapeutic efficacy of PEGylated liposomal doxorubicin in colon carcinoma.
Marjaneh Janani, Mahmoud Reza Jaafari, Leila Arabi
Research Square (Research Square) (2024)
Open Access
Marjaneh Janani, Mahmoud Reza Jaafari, Leila Arabi
Research Square (Research Square) (2024)
Open Access
CAR-T therapy in oral squamous cell carcinoma: Current innovations and future prospects
Inamul Hasan Madar, S. Vimal, Shazia Fathima, et al.
Oral Oncology Reports (2024) Vol. 10, pp. 100267-100267
Open Access
Inamul Hasan Madar, S. Vimal, Shazia Fathima, et al.
Oral Oncology Reports (2024) Vol. 10, pp. 100267-100267
Open Access
Leucine zipper-based SAIM imaging identifies therapeutic agents to disrupt the cancer cell glycocalyx for enhanced immunotherapy
Sangwoo Park, Justin H. Paek, Marshall J. Colville, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Sangwoo Park, Justin H. Paek, Marshall J. Colville, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
